New MFS-DLPSO-XGBoost AI model achieves 80% precision in cardiovascular risk assessment, endorsed by leading medical organizations as clinical trials show 41% reduction in missed diagnoses. A novel AI...
New research reveals how combining circadian-aligned fasting with arjuna and ashwagandha enhances nitric oxide dynamics, offering novel hypertension management strategies requiring medical supervision...
Emerging research highlights the efficacy of hibiscus, dandelion, and celery as natural diuretics for blood pressure management, while new FDA advisories caution against unregulated combinations with ...
Recent studies and AI innovations demonstrate yoga’s efficacy in lowering blood pressure, supported by WHO guidelines and wearable-driven data. WHO’s 2023 endorsement and tech-driven yoga ...
Recent studies and FDA actions highlight omega-3s’ role in diabetes prevention, blood pressure control, and sustainable sourcing, reshaping clinical and consumer perspectives. Emerging research ...
Recent studies reveal curcumin’s efficacy in reducing blood glucose and improving cardiovascular health, supported by enhanced bioavailability formulations and updated regulatory guidelines for ...
Recent studies demonstrate Curcumae kwangsiensis radix’s superior anti-thrombotic properties, with Guangxi-origin samples showing exceptional activity through advanced quality marker identificat...
Recent advancements in AI and chemometrics are transforming quality assessment of Curcumae kwangsiensis radix, offering new possibilities for standardized thrombosis treatments in traditional Chinese ...
New research demonstrates how 14:10 and 16:8 fasting windows improve blood pressure through dual mechanisms of endothelial function enhancement and gut microbiome modulation. Emerging evidence positio...
Recent studies confirm turmeric’s effectiveness in regulating blood sugar and blood pressure, with new formulations enhancing bioavailability, though caution is advised for those on blood thinne...
